We hypothesized that proteinase-activated receptor-2 (PAR 2 ) modulates intestinal injuries induced by ischemia/reperfusion. Ischemia (1 hour) plus reperfusion (6 hours) significantly delayed gastrointestinal transit (GIT) compared with sham operation. Intraduodenal injection of PAR 2 -activating peptide SLIGRL-NH 2 significantly accelerated transit in ischemia/reperfusion but not in sham-operated rats. GIT was significantly delayed in ischemia/reperfusion and sham-operated PAR 2 ؊/؊ mice compared with PAR 2 ؉/؉ . SLIGRL-NH 2 significantly accelerated transit in ischemia/reperfusion in PAR 2 ؉/؉ but not in PAR 2 ؊/؊ mice. Prevention of mast cell degranulation with cromolyn, ablation of visceral afferents with capsaicin, and antagonism of calcitonin generelated peptide (CGRP) and neurokinin-1 receptors with CGRP 8 -37 and RP67580, respectively, abolished the SLIGRL-NH 2 -induced stimulatory effect on transit in ischemia/reperfusion. Tissue damage was significantly reduced by SLIGRL-NH 2 ; this effect was not observed in cromolyn-, capsaicin-, or RP67580-treated rats but was detected following CGRP 8 -37 . Intestinal PAR 2 mRNA levels were not affected by SLIGRL-NH 2 in ischemia/reperfusion. We propose that PAR 2 modulates GIT and tissue damage in intestinal ischemia/reperfusion by a mechanism dependent on mast cells and visceral afferents. PAR 2 effect on transit might be mediated by CGRP and substance P, whereas the effect on tissue damage appears to involve substance P but not CGRP. PAR 2 might be a signaling system in the neuroimmune communication in intestinal ischemia/reperfusion.